Valsartan MDL Defendant ZHP Sanctioned for Not Following Discovery Orders



DOCUMENTS
  • Order


CAMDEN, N.J. — A special master in the MDL for cases involving allegedly contaminated valsartan-containing drugs has imposed sanctions against defendant Zhejiang Huahai Pharmaceutical Company Ltd. (ZHP) for violating an order compelling its CEO to appear for a deposition.

In a May 10 order, Hon. Thomas I. Vanaskie (Ret.) also sanctioned ZHP for refusing to produce the custodial file of its CEO’s chief of staff and other relevant documents.

The special master held that while the terminating sanctions sought by plaintiffs are not warranted, “plaintiffs are entitled to relief that attempts to cure the prejudice resulting from ZHP’s failure …






UPCOMING CONFERENCES




HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel

MORE DETAILS